Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study

BackgroundHigh-dose testosterone replacement therapy (TRT), paired with finasteride (type II 5α-reductase inhibitor), improves body composition, muscle strength, and bone mineral density (BMD) in older men, without inducing prostate enlargement—a side effect associated with TRT. Men with spinal cord...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dana M. Otzel, Larissa Nichols, Christine F. Conover, Stephen A. Marangi, Jayachandra R. Kura, Dominic K. Iannaccone, David J. Clark, Chris M. Gregory, Christopher F. Sonntag, Anita Wokhlu, Hans K. Ghayee, Michael J. McPhaul, Charles E. Levy, Charles A. Plumlee, Robert B. Sammel, Kevin T. White, Joshua F. Yarrow
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Neurology
Subjects:	androgen estrogen testosterone replacement hypogonadism spinal cord injury muscle
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2024.1479264/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study

Similar Items